Skip to content Skip to footer
Private-market investment is financing the next generation of AI businesses, and public-market investors may not need an invitation to Silicon Valley’s inner circle to participate. Wall Street’s next growth engine may already be under construction, financed by many willing to write enormous…
A $19 price target, a potential once-yearly treatment and a modest-market-share thesis put EPRX in focus For biotechnology investors, the most compelling opportunities sometimes involve a familiar medicine delivered in an unfamiliar, and potentially more valuable, way. That is the investment case…
October 6, 2026 — Healthcare dealmaking, nuclear power and optical networking put tangible business catalysts behind some of the market’s biggest advances. Option Care Health (OPCH), Ciena (CIEN) and Constellation Energy (CEG) lead a compelling cross-sector rally in the supplied trading snapshot,…